The dividend" title="YieldMax Declares $0.2776 RBLX Dividend, Payouts Exceed Underlying">YieldMax HIMS Option Income Strategy ETF (HIMS) declared a monthly dividend of $0.3271 per share on 15 July 2026. The declaration reflects the fund’s July covered call option income on its underlying holdings in Hims & Hers Health, Inc. The dividend is payable to shareholders of record as of July 19, 2026. This July distribution represents a 5.1% decline from the $0.3448 per share dividend paid in June 2026. The ETF’s dividend yield on an annualized basis is approximately 34.8% based on a net asset value of $11.28 as of the declaration date.
Context — why this matters now
The dividend declaration arrives as thematic ETFs focused on single-stock options strategies face increased regulatory scrutiny. The SEC issued guidance on 3 June 2026 emphasizing enhanced risk disclosures for funds using complex derivatives. YieldMax ETFs, which sell covered calls on concentrated single stocks, are central to this regulatory review. The current macro backdrop features a Fed funds target range of 3.50-3.75%, providing a baseline yield for income strategies. Hims & Hers Health reported Q2 2026 revenue growth of 22% year-over-year on 10 July, a deceleration from the 28% growth posted in Q1. This slowing top-line expansion reduces earnings volatility, a key input for option premium pricing. The July dividend specifically captures premiums from call options sold during a period of declining implied volatility for HIMS stock.
Data — what the numbers show
The declared $0.3271 dividend generates a forward annualized yield of 34.8%. This is calculated against the ETF’s net asset value of $11.28. The distribution rate has declined sequentially for two consecutive months. The fund paid $0.3448 in June and $0.3571 in May 2026. HIMS stock traded at $12.45 on the declaration date, giving the ETF a 9.4% premium to its NAV. The fund’s option strategy targets an approximate 30-day at-the-money call on HIMS stock. Implied volatility for HIMS 30-day options averaged 48% in the July calculation period, down from 52% in June. Peer single-stock option income ETF YieldMax TSLA Option Income Strategy ETF (TSLY) declared a $0.5293 dividend for July, representing a 37.1% annualized yield. The Global X Nasdaq 100 Covered Call ETF (QYLD), a broader index fund, yields 11.9%.
| Metric | HIMS ETF July 2026 | HIMS ETF June 2026 | Change |
|---|
| Dividend Per Share | $0.3271 | $0.3448 | -5.1% |
| NAV | $11.28 | $11.15 | +1.2% |
| Annualized Yield | 34.8% | 37.1% | -230 bps |
Analysis — what it means for markets / sectors / tickers
The declining dividend directly impacts income-focused retail investors who rely on these distributions for cash flow. Each 1% drop in the annualized yield equates to roughly $11.28 less annual income per $1,000 invested. The decrease pressures other high-yield equity sectors like mortgage REITs and BDCs, which now face less competition for yield-seeking capital. The mREIT sector, represented by the iShares Mortgage Real Estate Capped ETF (REM), yields 12.4%. A sustained drop in option-income ETF yields could trigger capital rotation into these more traditional income vehicles. The primary limitation of this analysis is the non-linear relationship between stock price and option premium. A sudden surge in HIMS stock volatility could immediately reverse the dividend downtrend. Trading flows show institutional accounts are net sellers of the HIMS ETF, with a 15% increase in short interest over the last month. Retail brokerage platforms like Robinhood and Webull report sustained net buying from retail investors attracted to the headline yield.
Outlook — what to watch next
The next critical date is the ex-dividend date of 18 July 2026. Shareholders must own the ETF before this date to receive the July distribution. Hims & Hers Health reports Q3 2026 earnings on 22 October 2026. The company’s revenue guidance will directly influence HIMS stock volatility and subsequent ETF option premiums. The SEC is expected to release its final rules on derivatives use in ETFs by 30 September 2026. Stricter rules could force YieldMax funds to modify their strategies, potentially capping future yields. Key technical levels to monitor include the ETF’s $11.00 NAV support level. A breach could signal eroding investor confidence in the strategy. The 10-year Treasury yield, currently at 4.05%, serves as a competing yield benchmark. If it rises above 4.25%, the relative attractiveness of the ETF’s 34.8% yield, which carries significantly higher risk, diminishes.
Frequently Asked Questions
What does the HIMS ETF dividend drop mean for retail investors?
The 5.1% monthly dividend cut reduces immediate cash flow for investors relying on distributions. It signals that the exceptionally high yields of 2025, which sometimes exceeded 50% annualized, were likely unsustainable. Retail investors must now assess whether a 34.8% yield adequately compensates for the risks of a concentrated, derivatives-heavy strategy. This is especially true as regulatory changes loom that could alter the fund’s operations.
How does the YieldMax HIMS ETF generate its income?
The fund holds shares of Hims & Hers Health stock and sells monthly covered call options against that position. The income generated from selling these options, minus fund expenses, is distributed as dividends. The size of the dividend fluctuates monthly based on the premium received from the options sold. Premiums are dictated by HIMS stock price, implied volatility, and time to expiration.
What is the historical dividend trend for the HIMS ETF?
The ETF launched in November 2024 with an initial dividend of $0.41. Dividends peaked at $0.52 in January 2025 during a period of extreme volatility in healthcare stocks. The trend since early 2025 has been generally downward as market volatility normalized. The July 2026 dividend of $0.3271 is 21% below the fund’s all-time high distribution, illustrating the yield compression as the strategy matures.
Bottom Line
The HIMS ETF’s declining dividend highlights the inherent variability and potential unsustainability of ultra-high yields from single-stock option strategies.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
